Filippo Pelizzaro

19PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCounselling psychologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 14, 2025
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study.

Elisa Pinto, Elisabetta Lazzarini, Filippo Pelizzaro

|Jan 08, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma.

Edoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres

|Jul 13, 2024
Alcoholic Etiology, Severity of Liver Disease, and Post-Transplant Adherence Are Correlated with Worse Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Liver Transplant Candidates.

Elisa Zanatta, Elisabetta Patron, Simone Messerotti Benvenuti

|Sep 27, 2023
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.

Filippo Pelizzaro, Franco Trevisani, Vittorio Simeon

|Jun 28, 2023
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies.

Elisa Pinto, Filippo Pelizzaro, Fabio Farinati

|May 16, 2023
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Strategies and Biomarkers Predicting Response and/or Resistance.

Filippo Pelizzaro, Fabio Farinati, Franco Trevisani

Pageof 4

Frequent Collaborators

7 joint publications

Franco Trevisani

6 joint publications

Alessandro Vitale

6 joint publications

Francesco Paolo Russo

5 joint publications

Edoardo Giovanni Giannini